The FDA approved nerandomilast (Jascayd) tablets for idiopathic pulmonary fibrosis (IPF), the first new product for the progressive lung condition in over a decade, the agency announced on Tuesday.

The Food and Drug Administration is recalling 16 brands of cinnamon that contain elevated lead levels, which over time can cause neurological problems including learning disabilities in young children ...

The Food and Drug Administration said in a pair of new health alerts that it has identified additional cinnamon products sold in the U.S. that were found to contain elevated levels of lead. In a Oct.

The Food and Drug Administration continues to warn consumers about 16 cinnamon products that contain lead, a warning initially announced in 2024. Ground cinnamon products from a dozen brands have been ...

Want to see more of NewsNation? Get 24/7 fact-based news coverage with the NewsNation app or add NewsNation as a preferred source on Google! (NewsNation) — The Food and Drug Administration has ...

NEW YORK (PIX11) — A popular brand of rice has issued a recall after it was reported that there could be small stones in the product. The stones originate from the rice farm, and if consumed, could ...

The U.S. Food and Drug Administration extended on Monday Denali Therapeutics Inc.’s (NASDAQ:DNLI) review timeline of the Biologics License Application (BLA), seeking accelerated approval of ...

A wide-reaching recall of fruit products has been initiated across 27 states due to the risk of lead contamination. The U.S. Food and Drug Administration (FDA) issued a warning that includes a range ...

Roche, which currently has investigational Alzheimer’s disease drug trontinemab in phase 3 trials, has secured FDA clearance of its blood-based biomarker test for the condition. The minimally invasive ...

Lizzy Lawrence spoke with more than 20 current and former FDA staff, interviewed legal experts, and reviewed agency documents to report this story. Lizzy Lawrence leads STAT’s coverage of the Food and ...

The U.S. Food and Drug Administration has approved Jascayd (nerandomilast) tablets to treat idiopathic pulmonary fibrosis (IPF). This is the first new therapy in more than 10 years to be approved for ...

BVI's FineVision HP trifocal IOL, approved by the FDA, enhances the US premium IOL market with advanced optic design for multifocal vision correction. The lens features a diffractive optic design and ...